Latest Quarterly Reports News

29Metals has withdrawn its full-year zinc production guidance following a seismic event at the Xantho Extended orebody in Western Australia, while maintaining outlooks for copper, gold, and silver.

WestStar Industrial’s subsidiary SIMPEC has landed a $115 million contract to expand residue filtration capacity at Alcoa’s Pinjarra Alumina Refinery, marking a key growth milestone.

DigitalX Limited has appointed William Hamilton as General Manager following the resignation of Interim CEO Demetrios Christou, as the company continues its search for a permanent CEO.

Atomos Limited has expanded its secured debt facility by $2 million, increasing its total borrowing capacity to $15.7 million, signaling confidence in its strategic turnaround and upcoming product launches.

PainChek’s UK pilot reveals significant clinical improvements and economic benefits, positioning the digital pain assessment app for broader adoption in Scotland and beyond.

Rewardle Holdings clarifies its complex relationship with CloudHolter and updates on Pepper Leaf loan litigation, addressing ASX concerns over financial reporting delays.

Connected Minerals has updated its quarterly reports for 2025 to provide detailed disclosures on the use of funds and exploration activities, addressing ASX compliance and shedding light on project developments in Namibia and Western Australia.

New Hope Corporation reported robust FY25 coal production and EBITDA despite severe weather and logistics disruptions at its Bengalla Mine, while New Acland Mine showed significant growth.

Nutritional Growth Solutions Ltd has clarified discrepancies in its June 2025 quarterly reports, attributing changes to timing and classification adjustments, while reaffirming its financial health and governance compliance.

Greatland Resources has downgraded its FY26 gold production target and significantly increased capital expenditure forecasts for its Telfer Project, prompting a sharp share price reaction and detailed ASX disclosure.

VDM Group remains suspended from ASX trading amid a legal dispute over its Angolan joint ventures, while pivoting towards new critical minerals opportunities in Australia.

HeraMED Limited has resumed trading on the ASX following the release of its quarterly reports and a significant capital raising announcement, marking a pivotal moment for the medical device company.